You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mesoblast

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Heart Failure Trial in Canada, United States (Allogeneic Mesenchymal Precursor Cells (MPCs), Sham Comparator)

Completed
  • Chronic Heart Failure
  • Allogeneic Mesenchymal Precursor Cells (MPCs)
  • Sham Comparator
  • Birmingham, Alabama
  • +58 more
Jan 5, 2022

Crohn Colitis Trial in Cleveland (Remestemcel-L, Placebo)

Recruiting
  • Crohn Colitis
  • Cleveland, Ohio
    Cleveland Clinic
Apr 4, 2022

Ulcerative Colitis Trial in Cleveland (Remestemcel-L, Placebo)

Recruiting
  • Ulcerative Colitis
  • Cleveland, Ohio
    Cleveland Clinic
Apr 4, 2022

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) Trial (Remestemcel-L,

Available
  • Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
  • Remestemcel-L
  • +2 more
  • (no location specified)
Apr 12, 2022

GVHD Trial in Durham (Prochymal®)

Completed
  • Graft Versus Host Disease
  • Durham, North Carolina
    Duke University
Jan 14, 2022

Grade B Acute GVHD, Grade C Acute GVHD, Grade D Acute GVHD Trial in United States (Remestemcel-L)

Completed
Has Results
  • Grade B Acute Graft Versus Host Disease
  • +2 more
  • Remestemcel-L
  • Los Angeles, California
  • +19 more
Feb 18, 2022

Recovery Following Partial Medial Meniscectomy Trial in United States (Chondrogen, Placebo)

Completed
  • Recovery Following Partial Medial Meniscectomy
  • Los Angeles, California
  • +3 more
Jan 7, 2022

Degenerative Disc Disease Trial in Australia, United States (Rexlemestrocel-L, Rexlemestrocel-L + HA Mixture, Placebo)

Completed
Has Results
  • Degenerative Disc Disease
  • Birmingham, Alabama
  • +47 more
Sep 22, 2022

Crohn's Disease Trial in Australia, New Zealand, United States (adult human mesenchymal stem cells)

Completed
  • Crohn's Disease
  • adult human mesenchymal stem cells
  • San Francisco, California
  • +19 more
Dec 3, 2021

Type 1 Diabetes, Type 1 Diabetes, Diabetes, Insulin-Dependent Trial in United States (PROCHYMAL®, Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • +3 more
  • Birmingham, Alabama
  • +19 more
Dec 20, 2021

Crohn's Disease Trial in Worldwide (Prochymal®, Placebo)

Completed
  • Crohn's Disease
  • Los Angeles, California
  • +55 more
Jan 11, 2022

Myocardial Infarction Trial in Canada, United States (Prochymal®, Placebo)

Completed
  • Myocardial Infarction
  • Gilbert, Arizona
  • +32 more
Jan 11, 2022

Crohn's Disease Trial in Canada, United States (Placebo, PROCHYMAL adult human mesenchymal stem cells)

Completed
  • Crohn's Disease
  • Placebo
  • PROCHYMAL adult human mesenchymal stem cells
  • Anaheim, California
  • +57 more
Dec 23, 2021

Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis Trial in United States (Prochymal™, Placebo)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • Los Angeles, California
  • +5 more
Dec 20, 2021

Grade B aGVHD, Grade C aGVHD, Grade D aGVHD Trial in United States (remestemcel-L)

Completed
Has Results
  • Grade B aGVHD
  • +2 more
  • Los Angeles, California
  • +19 more
Feb 18, 2022

Acute Myocardial Infarction Trial (Placebo, Mesenchymal Precursor Cells (MPC) 12.5 M, Mesenchymal Precursor Cells (MPC) 25 M)

Completed
Has Results
  • Acute Myocardial Infarction
  • Placebo
  • +2 more
  • (no location specified)
Jun 3, 2022

Recovery Following Partial Medial Meniscectomy Trial in United States (Mesenchymal Stem Cells, Hyaluronan)

Completed
  • Recovery Following Partial Medial Meniscectomy
  • Los Angeles, California
  • +7 more
Dec 23, 2021

Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19 Trial in New York (Remestemcel-L)

No longer available
  • Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
  • New York, New York
    Mount Sinai Hospital
Feb 17, 2021

Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))

Recruiting
  • Cardiovascular Diseases
  • Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
  • Nassau, The Bahamas, Bahamas
    The Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

Degenerative Disc Disease Trial in Australia, United States (Single Dose MPCs Injection, Single injection of saline solution,

Completed
  • Degenerative Disc Disease
  • Single Dose MPCs Injection
  • +2 more
  • Scottsdale, Arizona
  • +13 more
Jun 25, 2020

Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis Trial in United States (Lumbar Interbody Fusion with

Completed
  • Degenerative Disc Disease
  • +2 more
  • Lumbar Interbody Fusion with Autograft
  • Lumbar Interbody Fusion with NeoFuse
  • Santa Monica, California
  • +4 more
Jun 25, 2020

Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis Trial in New York (NeoFuse, posterolateral spinal fusion with

Completed
  • Degenerative Disc Disease
  • +2 more
  • NeoFuse
  • posterolateral spinal fusion with instrumentation
  • New York, New York
    Hospital for Special Surgery
Jun 25, 2020

Type 2 Diabetes Trial in United States (Mesenchymal Precursor Cells (MPCs))

Completed
  • Type 2 Diabetes
  • Mesenchymal Precursor Cells (MPCs)
  • Garden Grove, California
  • +17 more
Jun 1, 2020

Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis Trial in Clayton, Melbourne (NeoFuse,

Completed
  • Cervical Degenerative Disc Disease
  • +2 more
  • NeoFuse
  • MasterGraft Granules
  • Clayton, Victoria, Australia
  • +1 more
Jun 25, 2020